Update on Surgical Management of Small Bowel Neuroendocrine Tumors.

Published

Journal Article (Review)

The widespread use of endoscopy and imaging in combination with the continuous update of the staging systems for neuroendocrine tumors has led to an increase in the incidence of small intestinal neuroendocrine tumors (si-NENs) globally. Despite high survival rates, severe complications may occur even in early stages due to the anatomic location of the primary site and the desmoplastic reaction. Surgery plays a central role in the management of patients with si-NENs. Excision of locoregional disease along with extensive lymph node dissection should be performed in fit patients, even in the presence of metastases. Multimodality treatment of liver metastases includes hepatectomy, ablative techniques and liver transplantation. Hormone therapy with somatostatine analogs is of high importance for symptomatic control; special caution should be exercised both pre- and intra-operatively. A multidisciplinary approach is essential in order to provide personalized therapeutics for patients with si-NENs. Clinical research and specialization in this field should be further encouraged.

Full Text

Duke Authors

Cited Authors

  • Moris, D; Ntanasis-Stathopoulos, I; Tsilimigras, DI; Vagios, S; Karamitros, A; Karaolanis, G; Griniatsos, J; Papalampros, A; Papaconstantinou, I; Glantzounis, GK; Spartalis, E; Blazer, DG; Felekouras, E

Published Date

  • March 2018

Published In

Volume / Issue

  • 38 / 3

Start / End Page

  • 1267 - 1278

PubMed ID

  • 29491050

Pubmed Central ID

  • 29491050

Electronic International Standard Serial Number (EISSN)

  • 1791-7530

Digital Object Identifier (DOI)

  • 10.21873/anticanres.12349

Language

  • eng

Conference Location

  • Greece